|
| Press Releases |
|
 |
|
| Tuesday, June 16, 2015 |
|
|
China Everbright Limited's RMB Mezzanine Fund Enters into Joint Investment in AVIC Precision Casting Science and Technology Co., Ltd |
| China Everbright Limited ("CEL", Stock Code: 165.HK) announced that its RMB Mezzanine Fund has jointly invested with the Aviation Industry Corporation of China (AVIC), more info >> |
|
| Saturday, June 13, 2015 |
|
|
阳光100获光大安石战略入股 多方位战略合作加速转型升级 |
| 阳光100中国控股有限公司(「阳光100中国」或「公司」；股份代号：2608) 欣然宣布，阳光100与中国光大控股有限公司（HK：0165）（简称「光大控股」）旗下的EBA Investments (Advisory) Limited（「光大安石」）在北京签署战略合作框架协议。光大安石团队牵头的投资财团战略投资阳光100，成为持股比例为9.03%的第二大股东，同时光大安石将与阳光100确立多方位战略合作关系。 more info >> |
|
|
陽光100獲光大安石戰略入股 多方位戰略合作加速轉型升級 |
| 陽光100中國控股有限公司(「陽光100中國」或「公司」；股份代號：2608) 欣然宣布，陽光100與中國光大控股有限公司（HK：0165）（簡稱「光大控股」）旗下的EBA Investments (Advisory) Limited（「光大安石」）在北京簽署戰略合作框架協議。光大安石團隊牽頭的投資財團戰略投資陽光100，成爲持股比例爲9.03%的第二大股東，同時光大安石將與陽光100確立多方位戰略合作關係。 more info >> |
|
|
Sunshine 100 Receives Strategic Equity Investment from EBA |
| Sunshine 100 China Holdings Ltd ("Sunshine 100 China" or the "Company"); Stock code: 2608) is pleased to announce that the Company entered into a strategic cooperation framework agreement in Beijing with EBA Investments (Advisory) Limited ("EBA Investments"), a subsidiary of China Everbright Limited ("CEL", stock code: 0165.HK). more info >> |
|
| Friday, May 22, 2015 |
|
|
光大控股联合收购美国创新生物药公司Ambrx |
中国光大控股有限公司（以下简称「光大控股」，股份代號: 165.HK）旗下的医疗健康基金与复星医药、厚朴投资及药明康德宣布与Ambrx Inc（以下简称Ambrx）签订协议，根据协议上述机构将购买Ambrx的所有股份。在得到相关监管部门的批准且成交条件许可后，该交易预计将在2015年第二季度完成。
more info >> |
|
|
光大控股聯合收購美國創新生物藥公司Ambrx |
中國光大控股有限公司（以下簡稱「光大控股」，股份代號: 165.HK）旗下的醫療健康基金與復星醫藥、厚樸投資及藥明康得宣佈與Ambrx Inc（以下簡稱Ambrx）簽訂協議，根據協議上述機構將購買Ambrx的所有股份。在得到相關監管部門的批准且成交條件許可後，該交易預計將在2015年第二季度完成。
more info >> |
|
|
China Everbright Limited to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx |
| A consortium (the "Consortium") consisting of China Everbright Limited ("CEL", Stock Code: 165.HK)'s healthcare fund, Fosun Pharma, HOPU Investments and WuXi PharmaTech announced that the Consortium has signed a merger agreement pursuant to which the Consortium will acquire Ambrx Inc. ("Ambrx"). more info >> |
|
| Thursday, April 23, 2015 |
|
|
光大控股与中天嘉华集团签署合作协议 |
| 近日，中国光大控股有限公司 (简称「光大控股」，股份代号：165.HK) 与中天嘉华集团正式签署战略合作协议，开始面向信托受益权二级市场的全面合作。 more info >> |
|
|
光大控股與中天嘉華集團簽署合作協議 |
| 近日，中國光大控股有限公司 (簡稱「光大控股」，股份代號：165.HK) 與中天嘉華集團正式簽署戰略合作協議，開始面向信託受益權二級市場的全面合作。 more info >> |
|
|
China Everbright Limited and Sinowel Enterprise Group Sign a Partnership Agreement |
| Recently, China Everbright Limited ("CEL", stock code: 165.HK) and Sinowel Enterprise Group ({"Sinowel") announced the signing of a strategic partnership agreement to start their co-operation towards the secondary market of trust beneficiary rights. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Mitsubishi Corporation, KDDI CORPORATION, Lawson, Inc. Launching an Initiative to Transform into "Next-generation Convenience Store"
Sept 20, 2024 18:02 JST
|
|
|
Hitachi Rail is innovating and delivering transformative 5G digital signalling
Sept 20, 2024 16:47 JST
|
|
|
Olympus Launches New 4K Camera Head for Urological Endoscopy
Sept 20, 2024 15:00: JST
|
|
|
Seoul Metropolitan Government Intensifies Efforts to Become a Global Top 5 City by Attracting Singaporean Companies
Sept 20, 2024 14:00: JST
|
|
|
Olympus Launches New 4K Camera Head for Urological Endoscopy
Sept 20, 2024 15:00 JST
|
|
|
Seoul Metropolitan Government Intensifies Efforts to Become a Global Top 5 City by Attracting Singaporean Companies
Sept 20, 2024 13:00 HKT/SGT
|
|
|
Ching Lee Holdings (3728. HK) holds quality-driven strategies to acquire market share
Sept 20, 2024 12:27 HKT/SGT
|
|
|
正利工程以质取胜 争夺巿场份额
Sept 20, 2024 11:58 HKT/SGT
|
|
|
正利工程以質取勝 爭奪市場份額
Sept 20, 2024 11:38 HKT/SGT
|
|
|
Central Bank of Bahrain Grants Crypto.com Payment Service Provider Licence
Sept 20, 2024 07:00 HKT/SGT
|
|
|
興達國際控股有限公司關於解除與原員工關係的嚴正聲明
Sept 19, 2024 23:10 HKT/SGT
|
|
|
兴达国际控股有限公司关于解除与原员工关系的严正声明
Sept 19, 2024 22:46 HKT/SGT
|
|
|
Silicon FoundryとKearney、「The Collective // Supply Chain」を発表、将来に備えたサプライチェーンの傾向とソリューションの特定を支援
Sept 19, 2024 22:00: JST
|
|
|
Ainos、治療法が限られている希少疾患であるシェーグレン症候群の治療薬VELDONAの台湾での臨床試験開始計画を発表
Sept 19, 2024 21:00: JST
|
|
|
富士通とSTELLAR SCIENCE FOUNDATION、パートナーシップを締結し、若手研究者支援でイノベーション創出へ
Sept 19, 2024 18:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
